Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Health and Wellness Market

ID: MRFR/HC/19809-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

United States Health and Wellness Market Research Report: Size, Share, Trend Analysis By Sector (Personal Care & Beauty & Anti-Aging, Nutrition & Weight Loss, Physical Activity, Wellness Tourism, Preventive & Personalized Medicine, Spa Economy, and Others), – Competitor Industry Analysis and Trends Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Health and Wellness Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Sector (USD Billion)
  49.     4.1.1 Personal Care & Beauty & Anti-Aging
  50.     4.1.2 Nutrition & Weight Loss
  51.     4.1.3 Physical Activity
  52.     4.1.4 Wellness Tourism
  53.     4.1.5 Preventive & Personalized Medicine
  54.     4.1.6 Spa Economy
  55.     4.1.7 Others
  56.   4.2 Healthcare, BY Region (USD Billion)
  57.     4.2.1 North America
  58.       4.2.1.1 US
  59.       4.2.1.2 Canada
  60.     4.2.2 Europe
  61.       4.2.2.1 Germany
  62.       4.2.2.2 UK
  63.       4.2.2.3 France
  64.       4.2.2.4 Russia
  65.       4.2.2.5 Italy
  66.       4.2.2.6 Spain
  67.       4.2.2.7 Rest of Europe
  68.     4.2.3 APAC
  69.       4.2.3.1 China
  70.       4.2.3.2 India
  71.       4.2.3.3 Japan
  72.       4.2.3.4 South Korea
  73.       4.2.3.5 Malaysia
  74.       4.2.3.6 Thailand
  75.       4.2.3.7 Indonesia
  76.       4.2.3.8 Rest of APAC
  77.     4.2.4 South America
  78.       4.2.4.1 Brazil
  79.       4.2.4.2 Mexico
  80.       4.2.4.3 Argentina
  81.       4.2.4.4 Rest of South America
  82.     4.2.5 MEA
  83.       4.2.5.1 GCC Countries
  84.       4.2.5.2 South Africa
  85.       4.2.5.3 Rest of MEA
  86. 5 SECTION V: COMPETITIVE ANALYSIS
  87.   5.1 Competitive Landscape
  88.     5.1.1 Overview
  89.     5.1.2 Competitive Analysis
  90.     5.1.3 Market share Analysis
  91.     5.1.4 Major Growth Strategy in the Healthcare
  92.     5.1.5 Competitive Benchmarking
  93.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  94.     5.1.7 Key developments and growth strategies
  95.       5.1.7.1 New Product Launch/Service Deployment
  96.       5.1.7.2 Merger & Acquisitions
  97.       5.1.7.3 Joint Ventures
  98.     5.1.8 Major Players Financial Matrix
  99.       5.1.8.1 Sales and Operating Income
  100.       5.1.8.2 Major Players R&D Expenditure. 2023
  101.   5.2 Company Profiles
  102.     5.2.1 UnitedHealth Group (US)
  103.       5.2.1.1 Financial Overview
  104.       5.2.1.2 Products Offered
  105.       5.2.1.3 Key Developments
  106.       5.2.1.4 SWOT Analysis
  107.       5.2.1.5 Key Strategies
  108.     5.2.2 Anthem (US)
  109.       5.2.2.1 Financial Overview
  110.       5.2.2.2 Products Offered
  111.       5.2.2.3 Key Developments
  112.       5.2.2.4 SWOT Analysis
  113.       5.2.2.5 Key Strategies
  114.     5.2.3 Aetna (US)
  115.       5.2.3.1 Financial Overview
  116.       5.2.3.2 Products Offered
  117.       5.2.3.3 Key Developments
  118.       5.2.3.4 SWOT Analysis
  119.       5.2.3.5 Key Strategies
  120.     5.2.4 Cigna (US)
  121.       5.2.4.1 Financial Overview
  122.       5.2.4.2 Products Offered
  123.       5.2.4.3 Key Developments
  124.       5.2.4.4 SWOT Analysis
  125.       5.2.4.5 Key Strategies
  126.     5.2.5 Humana (US)
  127.       5.2.5.1 Financial Overview
  128.       5.2.5.2 Products Offered
  129.       5.2.5.3 Key Developments
  130.       5.2.5.4 SWOT Analysis
  131.       5.2.5.5 Key Strategies
  132.     5.2.6 CVS Health (US)
  133.       5.2.6.1 Financial Overview
  134.       5.2.6.2 Products Offered
  135.       5.2.6.3 Key Developments
  136.       5.2.6.4 SWOT Analysis
  137.       5.2.6.5 Key Strategies
  138.     5.2.7 Walgreens Boots Alliance (US)
  139.       5.2.7.1 Financial Overview
  140.       5.2.7.2 Products Offered
  141.       5.2.7.3 Key Developments
  142.       5.2.7.4 SWOT Analysis
  143.       5.2.7.5 Key Strategies
  144.     5.2.8 Kaiser Permanente (US)
  145.       5.2.8.1 Financial Overview
  146.       5.2.8.2 Products Offered
  147.       5.2.8.3 Key Developments
  148.       5.2.8.4 SWOT Analysis
  149.       5.2.8.5 Key Strategies
  150.     5.2.9 Medtronic (US)
  151.       5.2.9.1 Financial Overview
  152.       5.2.9.2 Products Offered
  153.       5.2.9.3 Key Developments
  154.       5.2.9.4 SWOT Analysis
  155.       5.2.9.5 Key Strategies
  156.     5.2.10 Johnson & Johnson (US)
  157.       5.2.10.1 Financial Overview
  158.       5.2.10.2 Products Offered
  159.       5.2.10.3 Key Developments
  160.       5.2.10.4 SWOT Analysis
  161.       5.2.10.5 Key Strategies
  162.   5.3 Appendix
  163.     5.3.1 References
  164.     5.3.2 Related Reports
  165. 6 LIST OF FIGURES
  166.   6.1 MARKET SYNOPSIS
  167.   6.2 NORTH AMERICA MARKET ANALYSIS
  168.   6.3 US MARKET ANALYSIS BY SECTOR
  169.   6.4 CANADA MARKET ANALYSIS BY SECTOR
  170.   6.5 EUROPE MARKET ANALYSIS
  171.   6.6 GERMANY MARKET ANALYSIS BY SECTOR
  172.   6.7 UK MARKET ANALYSIS BY SECTOR
  173.   6.8 FRANCE MARKET ANALYSIS BY SECTOR
  174.   6.9 RUSSIA MARKET ANALYSIS BY SECTOR
  175.   6.10 ITALY MARKET ANALYSIS BY SECTOR
  176.   6.11 SPAIN MARKET ANALYSIS BY SECTOR
  177.   6.12 REST OF EUROPE MARKET ANALYSIS BY SECTOR
  178.   6.13 APAC MARKET ANALYSIS
  179.   6.14 CHINA MARKET ANALYSIS BY SECTOR
  180.   6.15 INDIA MARKET ANALYSIS BY SECTOR
  181.   6.16 JAPAN MARKET ANALYSIS BY SECTOR
  182.   6.17 SOUTH KOREA MARKET ANALYSIS BY SECTOR
  183.   6.18 MALAYSIA MARKET ANALYSIS BY SECTOR
  184.   6.19 THAILAND MARKET ANALYSIS BY SECTOR
  185.   6.20 INDONESIA MARKET ANALYSIS BY SECTOR
  186.   6.21 REST OF APAC MARKET ANALYSIS BY SECTOR
  187.   6.22 SOUTH AMERICA MARKET ANALYSIS
  188.   6.23 BRAZIL MARKET ANALYSIS BY SECTOR
  189.   6.24 MEXICO MARKET ANALYSIS BY SECTOR
  190.   6.25 ARGENTINA MARKET ANALYSIS BY SECTOR
  191.   6.26 REST OF SOUTH AMERICA MARKET ANALYSIS BY SECTOR
  192.   6.27 MEA MARKET ANALYSIS
  193.   6.28 GCC COUNTRIES MARKET ANALYSIS BY SECTOR
  194.   6.29 SOUTH AFRICA MARKET ANALYSIS BY SECTOR
  195.   6.30 REST OF MEA MARKET ANALYSIS BY SECTOR
  196.   6.31 KEY BUYING CRITERIA OF HEALTHCARE
  197.   6.32 RESEARCH PROCESS OF MRFR
  198.   6.33 DRO ANALYSIS OF HEALTHCARE
  199.   6.34 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  200.   6.35 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  201.   6.36 SUPPLY / VALUE CHAIN: HEALTHCARE
  202.   6.37 HEALTHCARE, BY SECTOR, 2024 (% SHARE)
  203.   6.38 HEALTHCARE, BY SECTOR, 2024 TO 2035 (USD Billion)
  204.   6.39 BENCHMARKING OF MAJOR COMPETITORS
  205. 7 LIST OF TABLES
  206.   7.1 LIST OF ASSUMPTIONS
  207.     7.1.1
  208.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  209.     7.2.1 BY SECTOR, 2025-2035 (USD Billion)
  210.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  211.     7.3.1 BY SECTOR, 2025-2035 (USD Billion)
  212.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  213.     7.4.1 BY SECTOR, 2025-2035 (USD Billion)
  214.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  215.     7.5.1 BY SECTOR, 2025-2035 (USD Billion)
  216.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  217.     7.6.1 BY SECTOR, 2025-2035 (USD Billion)
  218.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  219.     7.7.1 BY SECTOR, 2025-2035 (USD Billion)
  220.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  221.     7.8.1 BY SECTOR, 2025-2035 (USD Billion)
  222.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  223.     7.9.1 BY SECTOR, 2025-2035 (USD Billion)
  224.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  225.     7.10.1 BY SECTOR, 2025-2035 (USD Billion)
  226.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  227.     7.11.1 BY SECTOR, 2025-2035 (USD Billion)
  228.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  229.     7.12.1 BY SECTOR, 2025-2035 (USD Billion)
  230.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  231.     7.13.1 BY SECTOR, 2025-2035 (USD Billion)
  232.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  233.     7.14.1 BY SECTOR, 2025-2035 (USD Billion)
  234.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  235.     7.15.1 BY SECTOR, 2025-2035 (USD Billion)
  236.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  237.     7.16.1 BY SECTOR, 2025-2035 (USD Billion)
  238.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  239.     7.17.1 BY SECTOR, 2025-2035 (USD Billion)
  240.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  241.     7.18.1 BY SECTOR, 2025-2035 (USD Billion)
  242.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  243.     7.19.1 BY SECTOR, 2025-2035 (USD Billion)
  244.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  245.     7.20.1 BY SECTOR, 2025-2035 (USD Billion)
  246.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  247.     7.21.1 BY SECTOR, 2025-2035 (USD Billion)
  248.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  249.     7.22.1 BY SECTOR, 2025-2035 (USD Billion)
  250.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  251.     7.23.1 BY SECTOR, 2025-2035 (USD Billion)
  252.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  253.     7.24.1 BY SECTOR, 2025-2035 (USD Billion)
  254.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  255.     7.25.1 BY SECTOR, 2025-2035 (USD Billion)
  256.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  257.     7.26.1 BY SECTOR, 2025-2035 (USD Billion)
  258.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  259.     7.27.1 BY SECTOR, 2025-2035 (USD Billion)
  260.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  261.     7.28.1 BY SECTOR, 2025-2035 (USD Billion)
  262.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  263.     7.29.1 BY SECTOR, 2025-2035 (USD Billion)
  264.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  265.     7.30.1 BY SECTOR, 2025-2035 (USD Billion)
  266.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  267.     7.31.1
  268.   7.32 ACQUISITION/PARTNERSHIP
  269.     7.32.1

Healthcare Market Segmentation

Healthcare By Sector (USD Billion, 2025-2035)

  • Personal Care & Beauty & Anti-Aging
  • Nutrition & Weight Loss
  • Physical Activity
  • Wellness Tourism
  • Preventive & Personalized Medicine
  • Spa Economy
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions